A Study of Baricitinib and Probenecid in Healthy Participants
Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
The purposes of this study are to assess how the body handles baricitinib when it is given
with another drug called probenecid. The study doctor will measure the amount of baricitinib
that is absorbed into the blood stream and the time that it takes to remove baricitinib from
the body. The safety and tolerability of these drugs will be studied. The study will last
about 18 days from the first dose to the end of the study (not including screening).